// App-Quantinova.ai

386 : HIGH NUMBERS OF PORTAL VENOUS CIRCULATING TUMOR CELLS ACQUIRED VIA EUS PROVIDE PROGNOSTIC ASSISTANCE FOR PROGRESSION FREE SURVIVAL IN PANCREATICOBILIARY CANCERS

Researchers

Presenter

  • Eric Swei

Principal Investigators

  • Ernesto Llano

  • Christopher G. Chapman

  • Betty Li

  • Rene S. Bermea

  • Kianoush Donboli

  • Daniel V. Catenacci

  • Uzma D. Siddiqui

  • Irving Waxman

Medical Centers

  • Department of Medicine, University of Chicago, Chicago

  • Center for Endoscopic Research and Therapeutics, The University of Chicago Medicine, Chicago, Illinois, United States

  • The University of Chicago Medical Center, Chicago, IL

  • Section of Hematology/Oncology, University of Chicago, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved